• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RBM15通过稳定NAE1来预防心肌梗死。

RBM15 Protects From Myocardial Infarction by Stabilizing NAE1.

作者信息

Cheng Hao, Wu Jian, Li Linnan, Song Xiaoyue, Xue Junqiang, Shi Yuekai, Zou Yunzeng, Ma Jianying, Ge Junbo

机构信息

Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.

Shanghai Institute of Cardiovascular Diseases, Shanghai, China.

出版信息

JACC Basic Transl Sci. 2024 Apr 10;9(5):631-648. doi: 10.1016/j.jacbts.2024.01.017. eCollection 2024 May.

DOI:10.1016/j.jacbts.2024.01.017
PMID:38984049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11228393/
Abstract

RNA-binding proteins play multiple roles in several biological processes. However, the roles of RBM15-an important RNA-binding protein and a significant regulator of RNA methylation-in cardiovascular diseases remain elusive. This study aimed to investigate the biological function of RBM15 and its fundamental mechanisms in myocardial infarction (MI). Methylated RNA immunoprecipitation sequencing was used to explore the N6-methyladenosine (mA) difference between MI and normal tissues. Our findings showed the elevated level of mA in MI, and its transcription profile in both MI and normal tissues. RBM15 was the main regulator and its overexpression attenuated apoptosis in cardiomyocytes and improved cardiac function in mice after MI. Then, we used one target NEDD8 activating enzyme E1 subunit and its inhibitor (MLN4924) to investigate the impact of RBM15 targets on cardiomyocytes. Finally, the enhanced mA methylation in the presence of RBM15 overexpression led to the increased expression and stability of NEDD8 activating enzyme E1 subunit. Our findings suggest that the enhanced mA level is a protective mechanism in MI, and RBM15 is significantly upregulated in MI and promotes cardiac function. This study showed that RBM15 affected MI by stabilizing its target on the cell apoptosis function, which might provide a new insight into MI therapy.

摘要

RNA结合蛋白在多个生物学过程中发挥多种作用。然而,重要的RNA结合蛋白RBM15(一种RNA甲基化的重要调节因子)在心血管疾病中的作用仍不清楚。本研究旨在探讨RBM15在心肌梗死(MI)中的生物学功能及其基本机制。采用甲基化RNA免疫沉淀测序技术探究MI组织与正常组织之间N6-甲基腺苷(m⁶A)的差异。我们的研究结果显示MI中m⁶A水平升高,以及其在MI和正常组织中的转录谱。RBM15是主要调节因子,其过表达可减轻心肌细胞凋亡,并改善MI后小鼠的心功能。然后,我们使用一种靶向NEDD8激活酶E1亚基及其抑制剂(MLN4924)来研究RBM15的靶点对心肌细胞的影响。最后,RBM15过表达时m⁶A甲基化增强导致NEDD8激活酶E1亚基的表达和稳定性增加。我们的研究结果表明,m⁶A水平升高是MI中的一种保护机制,RBM15在MI中显著上调并促进心功能。本研究表明,RBM15通过稳定其在细胞凋亡功能上的靶点来影响MI,这可能为MI治疗提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/bacaffc6d19e/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/f66ebc64f059/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/a3a4dc6299d3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/87b682ec0bd6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/2787a12d7d1c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/86185390feb6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/1638cc220872/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/30fe121b3977/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/bd29509289a9/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/bacaffc6d19e/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/f66ebc64f059/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/a3a4dc6299d3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/87b682ec0bd6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/2787a12d7d1c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/86185390feb6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/1638cc220872/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/30fe121b3977/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/bd29509289a9/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9f/11228393/bacaffc6d19e/gr8.jpg

相似文献

1
RBM15 Protects From Myocardial Infarction by Stabilizing NAE1.RBM15通过稳定NAE1来预防心肌梗死。
JACC Basic Transl Sci. 2024 Apr 10;9(5):631-648. doi: 10.1016/j.jacbts.2024.01.017. eCollection 2024 May.
2
RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.RBM15 通过 IGF2BP3 依赖性调节 TMBIM6 的稳定性促进喉鳞状细胞癌的进展。
J Exp Clin Cancer Res. 2021 Feb 26;40(1):80. doi: 10.1186/s13046-021-01871-4.
3
RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4.RBM15 通过 m6A 介导的 CLDN4 调控抑制妊娠期糖尿病小鼠后代的肝胰岛素敏感性。
Mol Med. 2023 Feb 20;29(1):23. doi: 10.1186/s10020-023-00615-8.
4
RBM15 drives the progression of lung adenocarcinoma by regulating N6-methyladenosine-mediated LDHA mRNA stability.RBM15 通过调控 N6-甲基腺苷介导的 LDHA mRNA 稳定性促进肺腺癌的进展。
Life Sci. 2024 Dec 1;358:123146. doi: 10.1016/j.lfs.2024.123146. Epub 2024 Oct 13.
5
RBM15 facilities lung adenocarcinoma cell progression by regulating RASSF8 stability through N6 Methyladenosine modification.RBM15通过N6甲基腺苷修饰调节RASSF8稳定性促进肺腺癌细胞进展。
Transl Oncol. 2024 Aug;46:102018. doi: 10.1016/j.tranon.2024.102018. Epub 2024 Jun 4.
6
RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent manner.RBM15通过以IGF2BP1依赖的方式调节YES1 mRNA的N6-甲基腺苷修饰来促进肝细胞癌进展。
Cell Death Discov. 2021 Oct 27;7(1):315. doi: 10.1038/s41420-021-00703-w.
7
Validated Impacts of N6-Methyladenosine Methylated mRNAs on Apoptosis and Angiogenesis in Myocardial Infarction Based on MeRIP-Seq Analysis.基于MeRIP-Seq分析的N6-甲基腺苷甲基化mRNA对心肌梗死细胞凋亡和血管生成的验证影响
Front Mol Biosci. 2022 Jan 28;8:789923. doi: 10.3389/fmolb.2021.789923. eCollection 2021.
8
Enhancing mA modification of lncRNA through METTL3 and RBM15 to promote malignant progression in bladder cancer.通过METTL3和RBM15增强lncRNA的mA修饰以促进膀胱癌的恶性进展。
Heliyon. 2024 Mar 19;10(7):e28165. doi: 10.1016/j.heliyon.2024.e28165. eCollection 2024 Apr 15.
9
Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.敲低 RBM15 通过调节 MYD88 mRNA 的 N6-甲基腺苷化修饰抑制结直肠癌细胞的增殖和转移
Cancer Biother Radiopharm. 2022 Dec;37(10):976-986. doi: 10.1089/cbr.2021.0226. Epub 2021 Nov 25.
10
Bioinformatic analyses of the role of m6A RNA methylation regulators in abdominal aortic aneurysm.m6A RNA甲基化调节剂在腹主动脉瘤中作用的生物信息学分析
Ann Transl Med. 2022 May;10(10):547. doi: 10.21037/atm-22-1891.

引用本文的文献

1
RBM15 promotes hypoxia/reoxygenation-induced ferroptosis in human cardiomyocytes by mediating m6A modification of ACSL4.RBM15通过介导ACSL4的m6A修饰促进缺氧/复氧诱导的人心肌细胞铁死亡。
Hereditas. 2025 Jul 18;162(1):135. doi: 10.1186/s41065-025-00453-0.
2
RNA Binding Motif Protein 15 (RBM15): Structure, Function and Its Research Progress in Tumors.RNA结合基序蛋白15(RBM15):结构、功能及其在肿瘤中的研究进展
Int J Gen Med. 2025 Jul 4;18:3635-3649. doi: 10.2147/IJGM.S519741. eCollection 2025.
3
Biological function of RNA-binding proteins in myocardial infarction: a potential emerging therapeutic limelight.

本文引用的文献

1
Circ-CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15.环状 CTNNB1 通过与 RBM15 相互作用通过 m6A 修饰驱动有氧糖酵解和骨肉瘤进展。
Cell Prolif. 2023 Jan;56(1):e13344. doi: 10.1111/cpr.13344. Epub 2022 Oct 1.
2
Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction.N6-甲基腺苷 RNA 甲基化调控因子在急性心肌梗死诊断及亚型分类中的综合分析。
J Immunol Res. 2022 Aug 24;2022:5173761. doi: 10.1155/2022/5173761. eCollection 2022.
3
Role of N6-methyladenosine Modification in Cardiac Remodeling.
RNA结合蛋白在心肌梗死中的生物学功能:一个潜在的新兴治疗焦点。
Cell Biosci. 2025 May 24;15(1):65. doi: 10.1186/s13578-025-01408-8.
4
Deciphering the roles of neddylation modification in hepatocellular carcinoma: Molecular mechanisms and targeted therapeutics.解读NEDDylation修饰在肝细胞癌中的作用:分子机制与靶向治疗
Genes Dis. 2024 Dec 6;12(4):101483. doi: 10.1016/j.gendis.2024.101483. eCollection 2025 Jul.
5
The Biological Mechanisms and Clinical Roles of RNA-Binding Proteins in Cardiovascular Diseases.RNA 结合蛋白在心血管疾病中的生物学机制和临床作用。
Biomolecules. 2024 Aug 25;14(9):1056. doi: 10.3390/biom14091056.
N6-甲基腺苷修饰在心脏重塑中的作用。
Front Cardiovasc Med. 2022 Feb 10;9:774627. doi: 10.3389/fcvm.2022.774627. eCollection 2022.
4
m6A modification: recent advances, anticancer targeted drug discovery and beyond.m6A 修饰:最新进展、抗癌靶向药物发现及其他。
Mol Cancer. 2022 Feb 14;21(1):52. doi: 10.1186/s12943-022-01510-2.
5
WTAP-mediated mA modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis.WTAP 介导的长链非编码 RNA DIAPH1-AS1 的 mA 修饰增强其稳定性,促进鼻咽癌的生长和转移。
Cell Death Differ. 2022 Jun;29(6):1137-1151. doi: 10.1038/s41418-021-00905-w. Epub 2022 Jan 8.
6
mA target microRNAs in serum for cancer detection.检测癌症的血清中靶 microRNAs。
Mol Cancer. 2021 Dec 20;20(1):170. doi: 10.1186/s12943-021-01477-6.
7
Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators Expression Identify Distinct Molecular Subtypes of Myocardial Infarction.N6-甲基腺苷RNA甲基化调节剂表达的综合分析鉴定出心肌梗死的不同分子亚型。
Front Cell Dev Biol. 2021 Oct 27;9:756483. doi: 10.3389/fcell.2021.756483. eCollection 2021.
8
Loss of mA methyltransferase METTL3 promotes heart regeneration and repair after myocardial injury.mA 甲基转移酶 METTL3 的缺失促进心肌损伤后的心脏再生和修复。
Pharmacol Res. 2021 Dec;174:105845. doi: 10.1016/j.phrs.2021.105845. Epub 2021 Aug 21.
9
Acute Myocardial Infarction With Cardiogenic Shock: - Navigating the Invasive Options in Clinical Management.急性心肌梗死伴心源性休克:临床管理中的侵入性治疗选择探讨
J Cardiothorac Vasc Anesth. 2021 Nov;35(11):3154-3157. doi: 10.1053/j.jvca.2021.07.014. Epub 2021 Jul 14.
10
Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma.血小板反应蛋白 1 和 2 以及 PEDF 抑制肝内胆管癌的血管生成并促进淋巴管生成。
J Hepatol. 2021 Dec;75(6):1377-1386. doi: 10.1016/j.jhep.2021.07.016. Epub 2021 Jul 28.